Orion Biotech Opportunities Corp.

Orion Biotech Opportunities Corp. (Nasdaq: ORIA) is a blank-check company that completed its initial public offering in 2021 with a stated focus on the biotechnology and life sciences sector. The SPAC was sponsored by Orion Biotech Opportunities LLC and targeted acquisition candidates operating across the global biotech landscape. On December 20, 2021, the company submitted a Form 10-Q/A — an amended quarterly report — to the SEC under accession number 0001213900-21-066369, revising disclosures contained in a previously filed quarterly report. The amendment reflects updated financial and operational information as ORIA progressed through its post-IPO period within the life sciences deal-search space. For complete filing history, sponsor profiles, and deal-stage tracking on ORIA and hundreds of other SPACs, sign up for full data access at SpacDesk.